Understanding How Patients with Mild Cognitive Impairment and Alzheimer’s Disease Present at First Encounter: Toward a Standardized Framework for Therapy Eligibility (P7-13.007)

Angelos Katramados; Hwasoo Shin; I. Vaughn; L. Poisson; Kelly Tundo; M. S. Novikova; Brien Smith

doi:10.1212/wnl.0000000000216909

June 9, 2026Neurology

Understanding How Patients with Mild Cognitive Impairment and Alzheimer’s Disease Present at First Encounter: Toward a Standardized Framework for Therapy Eligibility (P7-13.007)

View at Publisher

Ask AI

Bookmark

Share

Key Points

The study aims to describe the characteristics of patients with mild cognitive impairment and Alzheimer’s disease during their first health system encounter and identify eligibility barriers for anti-amyloid therapy.
Descriptive analysis of demographic and clinical characteristics of patients at their first encounter.
Utilized data from a large, integrated health system.
Focus on identifying barriers to therapy eligibility.
Identified various demographic and clinical characteristics of patients with mild cognitive impairment and Alzheimer’s disease.
Highlighted significant barriers to therapy eligibility related to anti-amyloid treatment.
Provided a foundation for developing a standardized framework for assessing therapy eligibility.

Implication

Describes the demographic and clinical characteristics at initial encounters in a healthcare system, identifying barriers to therapy eligibility.

Abstract

To describe the demographic and clinical characteristics of patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD) at their earliest recorded encounter in a large, integrated health system, and to identify barriers relevant to anti-amyloid therapy eligibility.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Katramados et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf3d6faef96ed7f0564cb https://doi.org/10.1212/wnl.0000000000216909

View at Publisher

Ask AI

Bookmark

Share

Understanding How Patients with Mild Cognitive Impairment and Alzheimer’s Disease Present at First Encounter: Toward a Standardized Framework for Therapy Eligibility (P7-13.007)

Key Points

Implication

Abstract

Discussion

Cite This Study

Understanding How Patients with Mild Cognitive Impairment and Alzheimer’s Disease Present at First Encounter: Toward a Standardized Framework for Therapy Eligibility (P7-13.007)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading